Case report of penile cancer recurrence treated with cetuximab combined with anlotinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Case report of penile cancer recurrence treated with cetuximab combined with anlotinib

Published:2022-02 Issue:2 Volume:10 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Dai Shuang¹^ORCID,Liu Yan‐Yang¹,Liu Tao²,Zhang Yu³,Luo De‐Yun⁴

Affiliation:

1. Lung Cancer Center Department of Medical Oncology West China Hospital Sichuan University Chengdu China

2. Department of Oncology The First Affiliated Hospital of Chengdu Medical CollegeChengdu Medical College Chengdu China

3. Department of Pathology West China Hospital Sichuan University Chengdu China

4. Department of Abdominal Oncology West China Hospital Sichuan University Chengdu China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.5443

Reference23 articles.

1. Prophylactic Pelvic Lymph Node Dissection in Patients with Penile Cancer

2. Prognostic factors in node-positive carcinoma of the penis

3. Penile carcinoma: a challenge for the developing World

4. Taxanes in Combination with Cisplatin and Fluorouracil for Advanced Penile Cancer: Preliminary Results

5. Advanced Squamous Cell Carcinoma of the Head and Neck: The Current Role of Cetuximab

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Catequentinib;Reactions Weekly;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP